Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor. Article uri icon

Overview

publication date

  • May 14, 2018

Research

keywords

  • Giant Cell Arteritis
  • Neoplasms
  • Polymyalgia Rheumatica

Identity

Scopus Document Identifier

  • 85047927700

Digital Object Identifier (DOI)

  • 10.1136/annrheumdis-2018-213672

PubMed ID

  • 29760158

Additional Document Info

volume

  • 78

issue

  • 7